Palo Alto Investors Sells Out Of Savient Pharmaceuticals

William Leland Edwards‘ fund, Palo Alto Investors, just reported cutting down its entire position in nano-cap company Savient Pharmaceuticals Inc (OTCMKTS:SVNTQ). In its latest 13F, Palo Alto revealed holding over 9.74 million shares of Savient.

Savient Pharmaceuticals Inc

Disclosure: none

Recommended Reading:

Phil Frohlich, Prescott Still Loading Up on China Marine Food Group

Hillhouse Capital Management Discloses New Stake in Qunar Cayman Islands

Noam Gottesman, GLG Partners Are Bullish on Tableau Software

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 44 percentage points in 21 months Learn how!

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!